Status:
COMPLETED
Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
University of Zurich
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-75 years
Brief Summary
TOPDOCS is a prospective cohort study including COPD patients from currently six study centers in Switzerland. Patients with COPD GOLD stages I-IV will be enrolled and followed-up annually for at leas...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Proven COPD (GOLD stages I-IV)
- Age: 40-75 years
- Exclusion criteria:
- Mental or physical disability precluding informed consent or compliance with the protocol
- Acute or recent (within the last 6 weeks) exacerbation of COPD
Exclusion
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT01527773
Start Date
May 1 2011
End Date
January 1 2017
Last Update
August 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Pneumology
Zurich, Canton of Zurich, Switzerland, 8091